At UT Southwestern Medical Center, we have assembled a multi-disciplinary and inter-departmental team of clinical and basic science investigators with diverse skills and expertise to evaluate the impact of altering the activity of the vagus nerve on hepatic metabolic pathways.
We hypothesize that manipulation of the activity of the vagus nerve holds the potential to improve glycemic control by directly altering hepatic metabolism. It is our goal to translate these insights into improved neuromodulatory therapies for the treatment of Type 2 Diabetes and non-alcoholic fatty liver disease.